Phalanx Biotech recently launched its CytoOneArray.
The Taiwanese company designed the chromosomal microarray for prenatal and postnatal detection of microdeletions and microduplications related to congenital disorders, especially developmental and intellectual delay disorders. According to Phalanx, CytoOneArray is capable of detecting 264 clinically confirmed disease regions and 41 subtelomere regions.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
